Wolverine Asset Management
CDIO icon

Wolverine Asset Management’s Cardio Diagnostics CDIO Stock Holding History

Wolverine Asset Management’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-104
Closed -$228 – 1758
2026
Q2 		$228 Hold
104
– – ﹤0.01% 1632
2026
Q1 		$203 Hold
104
– – ﹤0.01% 1643
2025
Q4 		$282 Hold
104
– – ﹤0.01% 1609
2025
Q3 		$417 Hold
104
– – ﹤0.01% 1546
2025
Q2 		$374 Sell
104
-1
-1% -$7 ﹤0.01% 1547
2025
Q1 		$1.04K Sell
105
-21
-17% -$327 ﹤0.01% 1456
2024
Q4 		$3.46K Hold
126
– – ﹤0.01% 1444
2024
Q3 		$842 Hold
126
– – ﹤0.01% 1538
2024
Q2 		$2.08K Hold
126
– – ﹤0.01% 1491
2024
Q1 		$5.36K Buy
126
+7
+6% +$399 ﹤0.01% 1382
2023
Q4 		$8.9K Sell
119
-41
-26% -$1.42K ﹤0.01% 1397
2023
Q3 		$1.63K Hold
160
– – ﹤0.01% 1662
2023
Q2 		$5.7K Buy
160
+109
+214% +$6.15K ﹤0.01% 1460
2023
Q1 		$6.01K Buy
+51
New +$4.02K ﹤0.01% 1519
2022
Q4 		– Sell
-7,132
Closed -$2.15M – 2141
2022
Q3 		$2.15M Sell
7,132
-2,155
-23% -$647K 0.02% 545
2022
Q2 		$2.77M Buy
9,287
+676
+8% +$201K 0.03% 459
2022
Q1 		$2.55M Buy
+8,611
New +$2.55M 0.02% 445

Other funds holding CDIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Wolverine Asset Management's CDIO Position: Q3 2026 in Review

Wolverine Asset Management sold out of Cardio Diagnostics (CDIO) in Q3 2026, closing a stake of 104 shares — an estimated $228 sold.

Wolverine Asset Management first reported a position in CDIO in Q1 2022 and held it in 17 quarters. The position peaked at $2.77M in Q2 2022. 3 funds tracked by Wall St. Rank hold CDIO as of Q3 2026.

  • Wolverine Asset Management reported no remaining Cardio Diagnostics position as of Q3 2026 after selling out during the quarter.
  • Wolverine Asset Management sold 104 Cardio Diagnostics shares in Q3 2026, an estimated $228.
  • Wolverine Asset Management first reported a position in Cardio Diagnostics in Q1 2022 and held it in 17 quarters.
  • Wolverine Asset Management's Cardio Diagnostics position peaked at $2.77M in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q3 2026.

Based on Wolverine Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.